| Date | Time | Source | Headline | Symbol | Company |
| 01/24/2012 | 4:05PM | Business Wire | Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV | NASDAQ:GILD | Gilead Sciences Inc |
| 01/20/2012 | 3:30AM | Zacks | The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals & Merck - Press R.. | NASDAQ:GILD | Gilead Sciences Inc |
| 01/19/2012 | 7:19PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/19/2012 | 8:15AM | Zacks | Gilead Clinches Pharmasset Buy - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 01/18/2012 | 7:15PM | Business Wire | U.S. Food and Drug Administration Approves New Formulations of Viread® for Use by Children Living With HIV | NASDAQ:GILD | Gilead Sciences Inc |
| 01/18/2012 | 4:40PM | Business Wire | Roy D. Baynes, MD, PhD, to Join Gilead Sciences as Senior Vice President, Oncology Therapeutics | NASDAQ:GILD | Gilead Sciences Inc |
| 01/17/2012 | 5:00PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/17/2012 | 5:00PM | Business Wire | Gilead Sciences Completes Acquisition of Pharmasset, Inc. | NASDAQ:GILD | Gilead Sciences Inc |
| 01/17/2012 | 11:35AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/12/2012 | 6:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/12/2012 | 1:25AM | Business Wire | Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc. | NASDAQ:GILD | Gilead Sciences Inc |
| 01/11/2012 | 12:23PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/10/2012 | 8:28PM | Dow Jones News | Merck Will Consider Deals To Expand Hepatitis C Drug Lineup | NASDAQ:GILD | Gilead Sciences Inc |
| 01/10/2012 | 2:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/10/2012 | 3:30AM | Zacks | The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Inhibitex, Gilead Sciences and Pharmasset - Press Releases | NASDAQ:GILD | Gilead Sciences Inc |
| 01/09/2012 | 10:05AM | Dow Jones News | Applications Given Early Antitrust Clearance | NASDAQ:GILD | Gilead Sciences Inc |
| 01/09/2012 | 3:02AM | Zacks | BMY Kicks Off 2012 Pharma Deals - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 01/06/2012 | 4:44PM | Business Wire | Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period | NASDAQ:GILD | Gilead Sciences Inc |
| 01/05/2012 | 5:00PM | Business Wire | Gilead Sciences to Present at the 30th Annual JPMorgan Healthcare Conference on Monday, January 9 | NASDAQ:GILD | Gilead Sciences Inc |
| 12/30/2011 | 9:31AM | PR Newswire (US) | Critical Alerts for Chevron, Gilead, Medtronic, Mattel, and Mead Johnson Nutrition Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 12/28/2011 | 11:37AM | Zacks | EU Nod for UTHR's Remodulin IV - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 12/28/2011 | 10:15AM | Zacks | Fate on Gilead Quad Set for Aug '12 - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 12/28/2011 | 8:33AM | Zacks | Pharma & Biotech Stock Review & Outlook - Industry Outlook | NASDAQ:GILD | Gilead Sciences Inc |
| 12/27/2011 | 7:00PM | Zacks | Pharma & Biotech Stock Review & Outlook - Zacks Analyst Interviews | NASDAQ:GILD | Gilead Sciences Inc |
| 12/27/2011 | 7:00PM | Zacks | Pharma & Biotech Stock Review & Outlook - Industry Outlook | NASDAQ:GILD | Gilead Sciences Inc |
| 12/24/2011 | 6:15PM | Dow Jones News | TIP SHEET: Fidelity Manager Sees Opportunity In Biotech Funding Crunch | NASDAQ:GILD | Gilead Sciences Inc |
| 12/23/2011 | 5:15PM | Business Wire | U.S. FDA Accepts New Drug Application for Gilead’s Once-Daily, Single-Tablet Quad HIV Regimen | NASDAQ:GILD | Gilead Sciences Inc |
| 12/23/2011 | 8:05AM | Dow Jones News | TIP SHEET: Fidelity Manager Sees Opportunity In Biotech Funding Crunch | NASDAQ:GILD | Gilead Sciences Inc |
| 12/22/2011 | 8:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 12/22/2011 | 3:30PM | Dow Jones News | TIP SHEET: Fidelity Manager Sees Opportunity In Biotech Funding Crunch | NASDAQ:GILD | Gilead Sciences Inc |